1. Association of immune-related pneumonitis with the efficacy of PD-1/PD-L1 inhibitors in non-small cell lung cancer. (May 2020) Authors: Cui, Pengfei; Huang, Di; Wu, Zhaozhen; Tao, Haitao; Zhang, Sujie; Ma, Junxun; Liu, Zhefeng; Wang, Jinliang; Huang, Ziwei; Chen, Shixue; Zheng, Xuan; Hu, Yi Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bending‐Insensitive Intrinsically Flexible Ultraviolet Encoding Devices Based on Piezoelectric Nanogenerator‐Supplied Liquid Crystalline Polymer Fabrics. Issue 33 (24th July 2022) Authors: Zheng, Xiaoxiong; Liu, Zhefeng; Wang, Rui; Chen, Aihua Journal: Small Issue: Volume 18:Issue 33(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Chinese expert consensus on the diagnosis and treatment of HER2‐altered non–small cell lung cancer. Issue 1 (28th November 2022) Authors: Zhang, Shirong; Wang, Wenxian; Xu, Chunwei; Zhang, Yongchang; Cai, Xiuyu; Wang, Qian; Song, Zhengbo; Li, Ziming; Yu, Jinpu; Zhong, Wenzhao; Wang, Zhijie; Liu, Jingjing; Liu, Anwen; Li, Wen; Zhan, Ping; Liu, Hongbing; Lv, Tangfeng; Miao, Liyun; Min, Lingfeng; Lin, Gen Journal: Thoracic cancer Issue: Volume 14:Issue 1(2023) Page Start: 91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors. Issue 12 (16th March 2023) Authors: Xu, Chunwei; Zhang, Yongchang; Wang, Wenxian; Wang, Qian; Li, Ziming; Song, Zhengbo; Wang, Jiandong; Yu, Jinpu; Liu, Jingjing; Zhang, Shirong; Cai, Xiuyu; Wu, Ming; Zhan, Ping; Liu, Hongbing; Lv, Tangfeng; Miao, Liyun; Min, Lingfeng; Li, Jiancheng; Liu, Baogang; Yuan, Jingping Journal: Thoracic cancer Issue: Volume 14:Issue 12(2023) Page Start: 1102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Comparing the financial reporting quality of Chinese and US public firms. Issue 4 (11th April 2018) Authors: Brown, Kareen; Elayan, Fayez A.; Li, Jingyu; Liu, Zhefeng Journal: China finance review international Issue: Volume 8:Issue 4(2018) Page Start: 399 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Comparing the financial reporting quality of Chinese and US public firms. Issue 4 (19th November 2018) Authors: Brown, Kareen; Elayan, Fayez A.; Li, Jingyu; Liu, Zhefeng Journal: China finance review international Issue: Volume 8:Issue 4(2018) Page Start: 399 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Crizotinib vs platinum‐based chemotherapy as first‐line treatment for advanced non‐small cell lung cancer with different ROS1 fusion variants. (13th March 2020) Authors: Xu, Haiyan; Zhang, Quan; Liang, Li; Li, Junling; Liu, Zhefeng; Li, Weihua; Yang, Lu; Yang, Guangjian; Xu, Fei; Ying, Jianming; Zhang, Shucai; Wang, Yan Journal: Cancer medicine Issue: Volume 9:Number 10(2020) Page Start: 3328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Damage index of reinforced concrete members based on the energy dissipation capability degradation. (2nd December 2019) Authors: Wang, Yukui; Liu, Zhefeng; Yang, Weijun; Hu, Yi; Chen, Yuping Journal: Structural design of tall and special buildings Issue: Volume 29:Number 2(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Does annual report readability explain the accrual anomaly?. Issue 3 (28th May 2021) Authors: Liu, Ming; Liu, Zhefeng Journal: Asian review of accounting Issue: Volume 29:Issue 3(2021) Page Start: 307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of apatinib as second-line therapy for advanced gastric cancer: a single-center observational study. Issue 2 (February 2018) Authors: Zhang, Yong; Gou, Miaomiao; Han, Chun; Li, Juan; Wang, Lijie; Qiao, Qian; Hu, Yi; Bai, Li; Liu, Zhefeng Journal: Anti-cancer drugs Issue: Volume 29:Issue 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗